Editas Medicine: Q3 Earnings Insights

Editas Medicine: Q3 Earnings Insights

Editas Medicine EDIT reported its Q3 earnings results on Wednesday, November 2, 2022 at 06:30 AM.

Here's what investors need to know about the announcement.


Editas Medicine beat estimated earnings by 5.81%, reporting an EPS of $-0.81 versus an estimate of $-0.86.

Revenue was down $6.16 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 2.46% increase in the share price the next day.

Here's a look at Editas Medicine's past performance:


Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -0.82 -0.79 -0.72 -0.82
EPS Actual -0.78 -0.74 -0.61 -0.57
Revenue Estimate 4.29M 3.85M 4.29M 4.78M
Revenue Actual 6.36M 6.77M 12.47M 6.20M

To track all earnings releases for Editas Medicine visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarnings